Growth in first year appears unaffected by prenatal SSRI use

03/20/2013 | HealthDay News

Taking selective serotonin reuptake inhibitors during pregnancy may not affect an infant's growth during the first year of life, according to a study published online in the American Journal of Psychiatry. Researchers found that babies born to mothers who took the antidepressants had comparable weight, length and head circumference as babies with no exposure to the drugs.

View Full Article in:

HealthDay News

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Chief Executive Officer
Center for Improving Value in Healthcare
Denver, CO
Quality Program Manager II, State Programs
Tufts Health Plan
Watertown, MA
Associate Director, Promotion Integrity
Bristol-Myers Squibb
Plainsboro, NJ
Vice President, Medicare Advantage
BCBS-Louisiana
Baton Rouge, LA
Director, Global Integrity and Compliance, Pharmaceuticals
Alcon
Fort Worth, TX